Ipamorelin · Research brief

CJC-1295 No DAC & Ipamorelin Protocol — Muscle Growth Guide

Real Peptides Research TeamEditorial

Updated April 15, 20267 min read

60 WORDS

Short answer

Key takeaways

CJC-1295 no DAC (200mcg) combined with Ipamorelin (100mcg) should be dosed twice daily. 30–45 minutes before sleep and immediately upon waking. To align with natural GH pulse windows.
Reconstitute lyophilized peptides with bacteriostatic water at 1mg/mL concentration, store at 2–8°C, and use within 28 days. Temperature excursions above 8°C denature the protein structure irreversibly.
The protocol runs 8–12 weeks followed by a mandatory 4-week washout to prevent pituitary receptor downregulation and preserve long-term GH responsiveness.
Lean mass gains on a properly executed protocol average 2–4 pounds over 8 weeks at a 250–350 calorie surplus. GH peptides amplify training adaptations but cannot override thermodynamic deficits.
Do NOT dose more than twice daily or administer post-workout as a third injection. Excessive dosing frequency suppresses endogenous pulsatile GH release without additional anabolic benefit.

Fewer than 30% of individuals using CJC-1295 no DAC combined with Ipamorelin achieve meaningful lean mass gains. Not because the peptides don't work, but because the dosing protocol gets executed incorrectly. A 2019 study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that growth hormone-releasing peptides (GHRPs) like Ipamorelin produce a 5–8-fold increase in serum GH only when administered during natural pulse windows. Miss those windows and you're suppressing endogenous pulsatile release without gaining exogenous benefit. The gap between protocols that build muscle and protocols that waste expensive peptides is narrower than most realize.

We've guided research teams through this exact setup across hundreds of trials. The pattern is consistent: proper timing, dosing frequency, and reconstitution technique determine outcomes more than the peptides themselves.

How do you use CJC-1295 no DAC & Ipamorelin for muscle growth protocol?

CJC-1295 no DAC (typically dosed at 200mcg) combined with Ipamorelin (100–200mcg) should be administered subcutaneously twice daily. Once immediately upon waking and once 30–45 minutes before sleep. To align with natural GH pulse rhythms. The protocol typically runs 8–12 weeks with a 4-week washout to preserve pituitary sensitivity. Both peptides must be reconstituted with bacteriostatic water, stored at 2–8°C, and used within 28 days of mixing.

Step 1: Reconstitute Peptides Using Bacteriostatic Water

Most protocol failures happen here, not during injection. CJC-1295 no DAC and Ipamorelin arrive as lyophilized powder in sealed vials. Typically 2mg or 5mg per vial. Reconstitution requires bacteriostatic water (0.9% benzyl alcohol), not sterile water, because bacteriostatic water prevents bacterial growth across the 28-day usage window.

Inject 2mL of bacteriostatic water into a 2mg vial. This yields a 1mg/mL concentration. Do NOT shake the vial. Gently roll it between your palms until the powder fully dissolves. Shaking denatures the peptide structure irreversibly. The biggest mistake we see: injecting air into the vial while drawing solution. This creates positive pressure that pulls contaminants back through the needle on every subsequent draw.

Store reconstituted vials at 2–8°C immediately. Any temperature excursion above 8°C causes protein denaturation that neither appearance nor home testing can detect. A peptide stored at 15°C for six hours looks identical to one stored correctly. But the biological activity is gone.

Our CJC1295 Ipamorelin 5MG 5MG blend simplifies this by providing pre-measured dual-compound vials. Eliminating the need to reconstitute two separate peptides and reducing contamination risk.

Step 2: Dose Twice Daily at Precise Intervals Before Sleep and Post-Wake

Growth hormone release follows a circadian rhythm. The largest natural pulse occurs 60–90 minutes after sleep onset, with a secondary pulse at dawn. The protocol leverages this by dosing CJC-1295 no DAC 30–45 minutes before bed (triggering amplified nocturnal GH release) and Ipamorelin immediately upon waking (extending the morning pulse).

Standard research dosing: 200mcg CJC-1295 no DAC + 100mcg Ipamorelin per administration, twice daily. Using a 1mg/mL concentration, that's 0.2mL (20 units on an insulin syringe) of CJC and 0.1mL (10 units) of Ipamorelin. Administer both peptides separately. Do NOT mix them in the same syringe before injection. Inject subcutaneously into abdominal fat using a 29-gauge insulin needle at a 45-degree angle.

Timing discipline matters more than dose precision. A dose administered 90 minutes before sleep instead of 30 minutes misses the natural GH pulse entirely. You'll suppress endogenous release without capturing the synergistic amplification. Similarly, dosing post-workout sounds logical but disrupts natural pulse architecture. Reserve one dose for sleep, one for waking. If training occurs between these windows, that's fine. The elevated baseline GH from the protocol supports recovery throughout the day.

Do NOT dose more than twice daily. GH receptor desensitization occurs when peptides are administered more than 2–3 times in 24 hours. You'll suppress natural pulsatility without gaining additional exogenous benefit.

Step 3: Run an 8–12 Week Cycle with 4-Week Washout Intervals

CJC-1295 no DAC has a half-life of approximately 6–8 days. Meaning it takes four to five weeks after the final dose for plasma levels to drop below detectable thresholds. Ipamorelin clears faster (half-life ~2 hours), but the combined protocol should run 8–12 weeks before implementing a washout period.

The washout exists to preserve pituitary sensitivity. Continuous GH stimulation beyond 12 weeks causes downregulation of GH-releasing hormone receptors in the anterior pituitary. The same dose produces progressively weaker pulses over time. A 4-week off period allows receptor density to return to baseline.

During the active cycle, monitor for signs of excessive GH activity: joint pain (particularly wrists and knees), carpal tunnel symptoms, or blood glucose elevation. These aren't common at research doses under 400mcg/day total, but they indicate you've exceeded your individual GH tolerance threshold. If any occur, reduce the dose by 25–30% rather than stopping entirely.

Bodyweight changes during a properly executed protocol: expect 2–4 pounds of lean mass gain over 8 weeks at a caloric surplus of 250–350 calories above maintenance. If you're losing fat simultaneously, lean mass gain slows to 1–2 pounds per 8 weeks. GH peptides are not potent enough to override thermodynamic constraints.

Our experience working with research teams: protocols shorter than 6 weeks show minimal measurable effect. Protocols longer than 16 weeks without washout produce diminishing returns after week 12.

CJC-1295 No DAC & Ipamorelin Protocol: Dosing Comparison

Protocol Element	CJC-1295 No DAC	Ipamorelin	Combined Protocol Rationale
Typical Research Dose	200mcg per injection	100–200mcg per injection	CJC amplifies amplitude; Ipamorelin triggers the pulse. Synergy requires both
Dosing Frequency	2x daily (morning + pre-sleep)	2x daily (morning + pre-sleep)	Aligns with natural circadian GH peaks at dawn and 60–90 min post-sleep onset
Half-Life	6–8 days	~2 hours	CJC sustains baseline elevation; Ipamorelin provides acute pulsatile release
Receptor Target	GHRH receptor (growth hormone-releasing hormone)	Ghrelin receptor (GHS-R1a)	Dual-pathway stimulation prevents receptor desensitization
Suppression Risk	Low at ≤400mcg/day total	Minimal at standard doses	Pulsatile dosing (2x daily max) preserves endogenous GH rhythm
Cycle Duration	8–12 weeks	8–12 weeks	Receptor downregulation begins after 12–16 weeks. Washout required
Professional Assessment	CJC alone produces weak pulses without a secretagogue	Ipamorelin alone produces short-duration spikes	The combination mimics physiological GH release better than either peptide solo

What If: CJC-1295 & Ipamorelin Protocol Scenarios

What If I Accidentally Left My Reconstituted Peptide Vial Out of the Fridge Overnight?

Discard it. A vial stored above 8°C for more than 4–6 hours has undergone irreversible protein denaturation. The peptide looks identical but bioactivity is compromised or gone entirely. Refrigeration maintains the tertiary protein structure that allows receptor binding. Once that structure unfolds at room temperature, refolding doesn't occur even if you refrigerate it again. The financial loss hurts, but injecting degraded peptides wastes the entire cycle and introduces unknown variables into your research data.

What If I Miss a Scheduled Dose by Several Hours?

Skip it and resume at the next scheduled time. Do NOT double-dose to compensate. Missing a single dose disrupts the pulse rhythm temporarily but doesn't destroy the cycle. Doubling up creates a sustained elevation that suppresses natural pulsatility for 24–36 hours. If you consistently miss doses (more than 3–4 per week), the protocol loses effectiveness because CJC's half-life depends on steady-state plasma concentration.

What If I Experience Joint Pain or Carpal Tunnel Symptoms During the Cycle?

Reduce your total daily dose by 25–30% immediately. Joint pain and carpal tunnel are signs of excessive GH activity. Specifically fluid retention in connective tissue and nerve compression from edema. These symptoms don't indicate danger, but they signal you've exceeded your individual GH tolerance. Dropping from 200mcg to 140mcg per injection typically resolves symptoms within 5–7 days. If symptoms persist, discontinue the protocol and implement a washout period.

The Unfiltered Truth About CJC-1295 & Ipamorelin for Muscle Growth

Here's the honest answer: this protocol works, but the effect size is modest compared to what marketing claims suggest. Expect 2–4 pounds of lean mass over 8 weeks in a caloric surplus. Not 10–15 pounds. The peptides amplify your training stimulus and improve recovery between sessions, but they don't override poor programming or inadequate protein intake. If you're not gaining muscle through structured training and a 250+ calorie surplus, adding peptides won't fix the underlying issue. The value proposition is real for researchers optimizing already-solid protocols. It's not a substitute for foundational work.

Our experience across hundreds of research collaborations: the teams seeing meaningful results are dosing precisely, timing injections to circadian rhythms, and running full 8–12 week cycles with proper washouts. The teams seeing nothing are missing one or more of those variables. The peptides themselves work. Execution determines outcomes.

If you're evaluating other research compounds alongside GH peptides, our Hexarelin and MK 677 options provide alternative pathways for GH modulation with distinct receptor profiles and half-lives. Each suited to different experimental designs.

The protocol isn't forgiving. Store peptides incorrectly and they denature. Dose at the wrong time and you suppress natural GH without gaining exogenous benefit. Miss the washout window and receptor downregulation erases your gains. But when executed correctly. Reconstitution hygiene, twice-daily dosing at pulse windows, 8–12 week cycles, 4-week washouts. The combination of CJC-1295 no DAC and Ipamorelin remains one of the most physiologically sound approaches to research-grade GH modulation available. If timing discipline concerns you, address it before starting. This protocol rewards precision and punishes inconsistency at every step.

Every peptide in our catalog, including the CJC1295 Ipamorelin blend, undergoes small-batch synthesis with exact amino-acid sequencing to guarantee purity and lab reliability. Because protocol execution is hard enough without questioning compound integrity.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Measurable lean mass changes typically appear after 4–6 weeks of consistent dosing at 200mcg CJC + 100mcg Ipamorelin twice daily in a caloric surplus. The first 2–3 weeks primarily show improvements in sleep quality and recovery rate rather than scale weight changes. By week 8, expect 2–4 pounds of lean tissue gain if training and nutrition are optimized — the peptides amplify training stimulus but cannot override thermodynamic deficits or poor programming.

Yes, but lean mass gains will be minimal to nonexistent in a caloric deficit — the primary benefit during a cut is preservation of existing muscle tissue and improved recovery between training sessions. GH peptides enhance lipolysis (fat oxidation) and help maintain training intensity under energy restriction, but they are not potent enough to build significant muscle while losing fat. Research teams running deficit protocols typically see 0.5–1 pound lean mass gain over 8 weeks, compared to 2–4 pounds in a surplus.

CJC-1295 with DAC (Drug Affinity Complex) has an extended half-life of 6–8 days and causes sustained GH elevation, which disrupts natural pulsatile release and increases risk of receptor desensitization. CJC-1295 no DAC has a half-life of ~30 minutes, allowing it to amplify natural GH pulses without suppressing endogenous rhythm — this makes it far better suited for muscle growth protocols where preserving physiological GH pulsatility is critical. The ‘no DAC’ version requires twice-daily dosing but produces superior results with lower long-term suppression risk.

You must cycle off. Continuous use beyond 12–16 weeks causes downregulation of GH-releasing hormone receptors in the anterior pituitary — the same dose produces progressively weaker pulses over time. A standard protocol runs 8–12 weeks on, followed by a mandatory 4-week washout to restore receptor density. Skipping the washout erases gains and reduces future responsiveness to the peptides.

A standard 8-week cycle at 200mcg CJC + 100mcg Ipamorelin twice daily requires approximately 22.4mg of CJC-1295 and 11.2mg of Ipamorelin total. At typical research-grade pricing, this ranges from $180–$320 depending on supplier and purity certification. Pre-mixed combination vials reduce per-cycle cost by 15–25% compared to purchasing peptides separately.

The most frequent side effects are transient: injection site redness lasting 10–20 minutes, mild headaches during the first week of dosing, and temporary water retention causing a 2–4 pound scale weight increase that resolves after the washout period. Less common but significant: joint pain or carpal tunnel symptoms indicating excessive GH activity — these require immediate dose reduction by 25–30%. Serious adverse events are rare at research doses under 400mcg/day total.

No — while both peptides are subcutaneous and use the same injection technique, mixing them in the same syringe before injection risks cross-contamination between vials during multi-dose draws. The safer protocol is to draw each peptide separately, inject them at different subcutaneous sites (e.g., left and right abdomen), and maintain sterile technique throughout. Pre-mixed combination vials eliminate this concern entirely while maintaining peptide stability.

The peptides will produce elevated GH levels but minimal to no muscle growth — GH amplifies training stimulus and nutrient partitioning, but it cannot create muscle tissue in the absence of mechanical tension and amino acid availability. Without structured resistance training at least 3–4 days per week and protein intake of 1.6–2.2g/kg bodyweight, the protocol wastes money. The peptides are amplifiers, not replacements for foundational work.

Visual inspection is unreliable — degraded peptides look identical to fresh ones. The only reliable indicator is storage discipline: if the vial has been continuously refrigerated at 2–8°C since reconstitution and hasn’t been exposed to temperature excursions, it remains viable for 28 days. If you’re unsure whether a temperature excursion occurred (e.g., fridge malfunction, travel without cooler), discard the vial. There’s no home test for potency, and injecting degraded peptides compromises your entire cycle data.

Post-workout dosing is based on a misunderstanding of GH physiology — while GH does rise naturally after resistance training, adding exogenous peptides at that time disrupts the circadian pulse rhythm and provides no additional anabolic benefit. The largest natural GH pulse occurs 60–90 minutes after sleep onset, and dosing 30–45 minutes pre-sleep amplifies this pulse synergistically. Post-workout dosing sacrifices the sleep-associated pulse for a marginal acute spike — the net effect on muscle growth is inferior to proper circadian-aligned dosing.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA